Back to search

Article

Clinical Performance of Cas13a-based Point-of-Care Lateral Flow Assay for Detecting<i>Neisseria gonorrhoeae</i>

2024-03-04

Abstract excerpt

<h4>Background</h4> Diagnosis of Neisseria (N.) gonorrhoeae is dependent on nucleic acid amplification testing (NAAT), which is not available in resource-limited settings where the prevalence of infection is highest. Recent advances in molecular diagnostics leveraging the high specificity of CRISPR enzymes can permit field-deployable, point-of-care lateral flow assays. We previously reported on the development and...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
e4c8ea29-c3df-594e-99a2-f114af153344
DOI
10.1101/2024.03.01.24303603
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Clinical Performance of Cas13a-based Point-of-Care Lateral Flow Assay for Detecting<i>Neisseria gonorrhoeae</i>DOI 10.1101/2024.03.01.24303603
Select a neighboring publication to make it the new centre.